Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.

Journal: Journal of managed care & specialty pharmacy •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Hoog MM, Vallarino C, Maldonado JM, et al. (2026). "Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.". Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2026.32.10.1173